Advances personalized cancer treatment
Cellply has raised €16M across 5 funding rounds from 10 investors, most recently a round in May 2026. Based in Bologna, Italy; founded 2013; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2026-05-13 | Other | €7.2M | CDP Venture Capital,ENEA Tech e Biomedical,existing shareholders | View deal → |
| 2023-09-29 | Other | €3.6M | LIFTT,Recomec,Schia Ventures | View deal → |
| 2022-01-26 | Other | €810k | Schia Ventures | View deal → |
| 2021-12-15 | Other | €2.0M | Indaco Venture Partners,Italian Angels for Growth,LIFTT,Meta Ventures,Recomec | View deal → |
| 2014-03-01 | Seed | €2.0M | Italian Angels for Growth,Zernike Meta Ventures | View deal → |
